This report was recently updated on November 16 2024 with the latest and most recent
market numbers
Global RNA Analysis Market Size, Trends & Analysis - Forecasts to 2029 By Product Type (Instruments, Kits & Reagents, and Services), By Technology (Real Time-PCR (qPCR), Microarray, Sequencing, and Others), By Application (Construction of RNA Expression Atlas, Epigenetics, Infectious Diseases & Pathogenesis, Alternative RNA Splicing, RNA Structure & Molecular Dynamics, Development & Delivery of RNA Therapeutics, and Others), By End-use (Government Institutes & Academic Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, and Contract Research Organizations (CROs)), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The RNA analysis market is projected to grow at a CAGR of 11.5% from 2024 to 2029.
The RNA analysis market is a vital sector within the larger area of genomics and molecular biology, with a crucial function in understanding gene expression analysis and regulation. RNA sequencing, for example, allows for the investigation of genome-wide transcriptions while also assisting in discovering new genes, transcripts, and other elements such as RNAs in the laboratory.
RNA analysis is used in various applications, including clinical diagnostics, drug discovery, and customized medicine. Researchers and healthcare practitioners employ RNA analysis to find illness biomarkers, track disease progression, and design targeted medications. It is important in transcriptomics research, infectious illness studies, and next-generation sequencing, where knowing RNA expression patterns can lead to significant advancements in therapy and preventative methods. RNA-seq (RNA-sequencing) is a technique that employs next-generation sequencing (NGS) to determine the amount and pattern of RNA in a specimen. It studies the transcriptome in order to determine what genes are activated or dormant and to what extent.
In RNA sequencing, processing multiple samples in a single run may appear cost-effective. However, this reduces the number of reads and success rate per sample. It is critical to strike a compromise between adequate read depth for data quality and accuracy and optimizing sequencing capacity to ensure relevant biological samples are produced.
The kits & reagents segment is expected to hold the largest share of the market. RNA extraction kits use revolutionary chip design and high-quality reagents to conduct reliable and accurate RNA studies in minutes. Because of simplified chip preparation processes and reduced sample and reagent volume requirements, experiments can be completed quickly and with little hands-on time. These products are intended to improve the purity and check RNA integrity assessment of the samples, which is required for precise gene expression profiling and improving RNA sequencing technologies.
The services segment is expected to be the fastest-growing segment in the market from 2024 to 2029. RNA analysis services are provided by different companies such as Zymo Research, Qiagen, and Promega, including RNA extraction and purification, RNA sequencing (RNA-Seq), RNA quantification, and quality control. RNA analysis services include mRNA sequencing, transcriptome profiling, gene expression profiling, and complete solutions, including RNA sample preparation, library creation, and sequencing. This is expected to boost demand for these kinds of services in the coming years.
The real time-PCR (qPCR) segment is analyzed to hold the largest market share from 2024 to 2029. Quantitative real-time PCR (qPCR) is a solid RNA testing method that precisely determines the quantity of RNA in a specimen. It determines whether or not a given RNA sequence exists and how much there is, making it valuable for investigating gene activity and diagnosing disorders. The sensitivity and accuracy of qPCR make it ideal for immediately evaluating RNA modifications in research and healthcare settings, providing precise insights into genetic diseases and treating them accordingly.
The sequencing segment is analyzed to be the fastest-growing segment in the market from 2024 to 2029. RNA-seq is a high-throughput nucleic acid sequencing technique that determines the nucleotide sequence of RNA molecules and the abundance of specific RNA species within RNA molecule populations. Recognizing the transcriptome is crucial for connecting the information found in the genome to functional protein creation. RNA-seq can determine which of the genes are active in a given cell, their transcription level, and when they become active or inactive.
The infectious diseases & pathogenesis segment is analyzed to hold the largest market share of the market from 2024 to 2029. Infections are complex and changing processes involving both bacteria and hosts. As a result, it is crucial to identify key cells that will invade the host's cells. Next-generation sequencing is changing how diseases and individuals are treated. Different approaches for assessing gene expression and RNA biomarkers are finding their way into clinical settings to improve healthcare. The market's importance in infectious illnesses is reinforced by ongoing global health issues such as pandemics and outbreaks, which encourage constant innovation and use of RNA research tools for diagnostic and clinical purposes.
The epigenetics segment is analysed to be the fastest-growing segment in the market from 2024 to 2029. Epigenetics is rapidly growing within the RNA analysis market due to its critical role in understanding how genes operate and disease mechanisms. Because genetic changes such as DNA methylation and histone modifications can alter the interaction of genes and other regulatory protein molecules, epigenetic research to explore gene expression are anticipated to be in high demand in the coming years.
The government institutes & academic centers segment is analyzed to hold the largest market share of the market from 2024 to 2029. Government institutes and academic centres are important hubs for scientific research and development. RNA analysis is a critical component of this study, allowing researchers to investigate High-throughput RNA analysis, gene expression, regulation, and function. This funding goes toward research programs, infrastructure, and the purchase of improved RNA analysis technologies. The increasing use of transcriptomics analysis using technological development is driving up demand in both the pharmaceutical and biotech industries. Non-coding RNA analysis is being researched to gain a better understanding of RNA molecules that do not contain proteins yet play critical roles in gene regulation and cell function.
The contract research organizations (CROs) segment is analysed to be the fastest-growing segment in the market from 2024 to 2029. CROs specialize in delivering outsourced research services to the pharmaceutical, biotechnology, and healthcare industries. They are instrumental when undertaking large-scale investigations, clinical trials, and experimental research initiatives that require extensive High-throughput RNA analysis. CROs use their specialized knowledge and cutting-edge facilities to accomplish RNA isolation methods, sequencing, and RNA bioinformatics analysis swiftly and cost-effectively.
North America is expected to be the largest region in the global market. The expansion is due to the quick creation of healthcare programs, increasing focus on transcriptomics studies, and huge financing support for research and development in biomedical industry. The area is home to major enterprises and research organizations that are pioneering developments in RNA based diagnostics, single-cell RNA analysis, and RNA sequencing data analysis, all of which contribute substantially to the growth of the market.
Asia Pacific is predicted to witness rapid growth during the forecast period. As investments in biotechnology and healthcare infrastructure expand, Asia Pacific is aggressively pursuing RNA analysis research and development. The life-science industry's ongoing development, increased academic and government investment in transcriptome analysis, and research on RNA interference have contributed to the market's significant growth.
Pacific Bioscience of California, Inc., Promega, QIAGEN, Merck KGaA, Illumina, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Affymetrix, Inc., Danaher, and Eurofins Scientific, among others, are some of the key players operating in the RNA analysis market.
Please note: This is not an exhaustive list of companies profiled in the report.
On September 26, 2023, Merck became first provider to offer fully integrated mRNA Services. It offers integrated services for all critical stages of mRNA development, manufacturing, and commercialization, including products and testing.
On June 06, 2024, Bio-Rad launched ddSEQ Single-Cell RNA-Seq Kit for single cell gene expression. The RNA-Seq Kit delivers high-quality single-cell RNA-Seq libraries in a fast, efficient, and affordable workflow, allowing researchers to conduct single-cell gene expression and regulation analyses easily.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
3 GLOBAL MARKET OUTLOOK
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Technology Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 GLOBAL RNA ANALYSIS MARKET, BY PRODUCT TYPE
4.1 Introduction
4.2 RNA Analysis Market: Product Type Scope Key Takeaways
4.3 Revenue Growth Analysis, 2023 & 2029
4.4 Instruments
4.4.1 Instruments Market Estimates and Forecast, 2021-2029 (USD Million)
4.5 Kits & Reagents
4.5.1 Kits & Reagents Market Estimates and Forecast, 2021-2029 (USD Million)
4.6 Services
4.6.1 Services Market Estimates and Forecast, 2021-2029 (USD Million)
5 GLOBAL RNA ANALYSIS MARKET, BY TECHNOLOGY
5.1 Introduction
5.2 RNA Analysis Market: Technology Scope Key Takeaways
5.3 Revenue Growth Analysis, 2023 & 2029
5.4 Real Time-PCR (qPCR)
5.4.1 Real Time-PCR (qPCR) Market Estimates and Forecast, 2021-2029 (USD Million)
5.5 Microarray
5.5.1 Microarray Market Estimates and Forecast, 2021-2029 (USD Million)
5.6 Sequencing
5.6.1 Sequencing Market Estimates and Forecast, 2021-2029 (USD Million)
5.7 Others
5.7.1 Others Market Estimates and Forecast, 2021-2029 (USD Million)
6 GLOBAL RNA ANALYSIS MARKET, BY APPLICATION
6.1 Introduction
6.2 RNA Analysis Market: Application Scope Key Takeaways
6.3 Revenue Growth Analysis, 2023 & 2029
6.4 Construction of RNA Expression Atlas
6.4.1 Construction of RNA Expression Atlas Market Estimates and Forecast, 2021-2029 (USD Million)
6.5 Epigenetics
6.5.1 Epigenetics Market Estimates and Forecast, 2021-2029 (USD Million)
6.6 Infectious Diseases & Pathogenesis
6.6.1 Infectious Diseases & Pathogenesis Market Estimates and Forecast, 2021-2029 (USD Million)
6.7 Alternative RNA Splicing
6.7.1 Alternative RNA Splicing Market Estimates and Forecast, 2021-2029 (USD Million)
6.8 RNA Structure & Molecular Dynamics
6.8.1 RNA Structure & Molecular Dynamics Market Estimates and Forecast, 2021-2029 (USD Million)
6.9 Development & Delivery of RNA Therapeutics
6.9.1 Development & Delivery of RNA Therapeutics Market Estimates and Forecast, 2021-2029 (USD Million)
6.10 Others
6.10.1 Others Market Estimates and Forecast, 2021-2029 (USD Million)
7 GLOBAL RNA ANALYSIS MARKET, BY END-USE
7.1 Introduction
7.2 RNA Analysis Market: End-use Scope Key Takeaways
7.3 Revenue Growth Analysis, 2023 & 2029
7.4 Government Institutes & Academic Centers
7.4.1 Government Institutes & Academic Centers Market Estimates and Forecast, 2021-2029 (USD Million)
7.5 Pharmaceutical & Biotechnology Companies
7.5.1 Pharmaceutical & Biotechnology Companies Market Estimates and Forecast, 2021-2029 (USD Million)
7.6 Hospitals & Clinics
7.6.1 Hospitals & Clinics Market Estimates and Forecast, 2021-2029 (USD Million)
7.7 Contract Research Organizations (CROs)
7.7.1 Contract Research Organizations (CROs) Market Estimates and Forecast, 2021-2029 (USD Million)
8 GLOBAL RNA ANALYSIS MARKET, BY REGION
8.1 Introduction
8.2 North America RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.2.1 By Product Type
8.2.2 By Technology
8.2.3 By Application
8.2.4 By End-use
8.2.5 By Country
8.2.5.1 U.S. RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.2.5.1.1 By Product Type
8.2.5.1.2 By Technology
8.2.5.1.3 By Application
8.2.5.1.4 By End-use
8.2.5.2 Canada RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.2.5.2.1 By Product Type
8.2.5.2.2 By Technology
8.2.5.2.3 By Application
8.2.5.2.4 By End-use
8.2.5.3 Mexico RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.2.5.3.1 By Product Type
8.2.5.3.2 By Technology
8.2.5.3.3 By Application
8.2.5.3.4 By End-use
8.3 Europe RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.3.1 By Product Type
8.3.2 By Technology
8.3.3 By Application
8.3.4 By End-use
8.3.5 By Country
8.3.5.1 Germany RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.3.5.1.1 By Product Type
8.3.5.1.2 By Technology
8.3.5.1.3 By Application
8.3.5.1.4 By End-use
8.3.5.2 U.K. RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.3.5.2.1 By Product Type
8.3.5.2.2 By Technology
8.3.5.2.3 By Application
8.3.5.2.4 By End-use
8.3.5.3 France RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.3.5.3.1 By Product Type
8.3.5.3.2 By Technology
8.3.5.3.3 By Application
8.3.5.3.4 By End-use
8.3.5.4 Italy RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.3.5.4.1 By Product Type
8.3.5.4.2 By Technology
8.3.5.4.3 By Application
8.3.5.4.4 By End-use
8.3.5.5 Spain RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.3.5.5.1 By Product Type
8.3.5.5.2 By Technology
8.3.5.5.3 By Application
8.3.5.5.4 By End-use
8.3.5.6 Netherlands RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.3.5.6.1 By Product Type
8.3.5.6.2 By Technology
8.3.5.6.3 By Application
8.3.5.6.4 By End-use
8.3.5.7 Rest of Europe RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.3.5.7.1 By Product Type
8.3.5.7.2 By Technology
8.3.5.7.3 By Application
8.3.5.7.4 By End-use
8.4 Asia Pacific RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.4.1 By Product Type
8.4.2 By Technology
8.4.3 By Application
8.4.4 By End-use
8.4.5 By Country
8.4.5.1 China RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.4.5.1.1 By Product Type
8.4.5.1.2 By Technology
8.4.5.1.3 By Application
8.4.5.1.4 By End-use
8.4.5.2 Japan RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.4.5.2.1 By Product Type
8.4.5.2.2 By Technology
8.4.5.2.3 By Application
8.4.5.2.4 By End-use
8.4.5.3 India RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.4.5.3.1 By Product Type
8.4.5.3.2 By Technology
8.4.5.3.3 By Application
8.4.5.3.4 By End-use
8.4.5.4 South Korea RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.4.5.4.1 By Product Type
8.4.5.4.2 By Technology
8.4.5.4.3 By Application
8.4.5.4.4 By End-use
8.4.5.5 Singapore RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.4.5.5.1 By Product Type
8.4.5.5.2 By Technology
8.4.5.5.3 By Application
8.4.5.5.4 By End-use
8.4.5.6 Malaysia RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.4.5.6.1 By Product Type
8.4.5.6.2 By Technology
8.4.5.6.3 By Application
8.4.5.6.4 By End-use
8.4.5.7 Thailand RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.4.5.7.1 By Product Type
8.4.5.7.2 By Technology
8.4.5.7.3 By Application
8.4.5.7.4 By End-use
8.4.5.8 Indonesia RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.4.5.8.1 By Product Type
8.4.5.8.2 By Technology
8.4.5.8.3 By Application
8.4.5.8.4 By End-use
8.4.5.9 Vietnam RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.4.5.9.1 By Product Type
8.4.5.9.2 By Technology
8.4.5.9.3 By Application
8.4.5.9.4 By End-use
8.4.5.10 Taiwan RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.4.5.10.1 By Product Type
8.4.5.10.2 By Technology
8.4.5.10.3 By Application
8.4.5.10.4 By End-use
8.4.5.11 Rest of Asia Pacific RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.4.5.11.1 By Product Type
8.4.5.11.2 By Technology
8.4.5.11.3 By Application
8.4.5.11.4 By End-use
8.5 Middle East and Africa RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.5.1 By Product Type
8.5.2 By Technology
8.5.3 By Application
8.5.4 By End-use
8.5.5 By Country
8.5.5.1 Saudi Arabia RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.5.5.1.1 By Product Type
8.5.5.1.2 By Technology
8.5.5.1.3 By Application
8.5.5.1.4 By End-use
8.5.5.2 U.A.E. RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.5.5.2.1 By Product Type
8.5.5.2.2 By Technology
8.5.5.2.3 By Application
8.5.5.2.4 By End-use
8.5.5.3 Israel RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.5.4.3.1 By Product Type
8.5.4.3.2 By Technology
8.5.4.3.3 By Application
8.5.5.3.4 By End-use
8.5.5.4 South Africa RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.5.5.4.1 By Product Type
8.5.5.4.2 By Technology
8.5.5.4.3 By Application
8.5.5.4.4 By End-use
8.5.5.5 Rest of Middle East and Africa RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.5.5.5.1 By Product Type
8.5.5.5.2 By Technology
8.5.5.5.2 By Application
8.5.5.5.4 By End-use
8.6 Central and South America RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.6.1 By Product Type
8.6.2 By Technology
8.6.3 By Application
8.6.4 By End-use
8.6.5 By Country
8.6.5.1 Brazil RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.6.5.1.1 By Product Type
8.6.5.1.2 By Technology
8.6.5.1.3 By Application
8.6.5.1.4 By End-use
8.6.5.2 Argentina RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.6.5.2.1 By Product Type
8.6.5.2.2 By Technology
8.6.5.2.3 By Application
8.6.5.2.4 By End-use
8.6.5.3 Chile RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.6.5.3.1 By Product Type
8.6.5.3.2 By Technology
8.6.5.3.3 By Application
8.6.5.5.4 By End-use
8.6.5.4 Rest of Central and South America RNA Analysis Market Estimates and Forecast, 2021-2029 (USD Million)
8.6.5.4.1 By Product Type
8.6.5.4.2 By Technology
8.6.5.4.3 By Application
8.6.5.4.4 By End-use
9 COMPETITIVE LANDCAPE
9.1 Company Market Share Analysis
9.2 Four Quadrant Positioning Matrix
9.2.1 Market Leaders
9.2.2 Market Visionaries
9.2.3 Market Challengers
9.2.4 Niche Market Players
9.3 Vendor Landscape
9.3.1 North America
9.3.2 Europe
9.3.3 Asia Pacific
9.3.4 Rest of the World
9.4 Company Profiles
9.4.1 Pacific Bioscience of California, Inc.
9.4.1.1 Business Description & Financial Analysis
9.4.1.2 SWOT Analysis
9.4.1.3 Products & Services Offered
9.4.1.4 Strategic Alliances between Business Partners
9.4.2 Promega
9.4.2.1 Business Description & Financial Analysis
9.4.2.2 SWOT Analysis
9.4.2.3 Products & Services Offered
9.4.2.4 Strategic Alliances between Business Partners
9.4.3 QIAGEN
9.4.3.1 Business Description & Financial Analysis
9.4.3.2 SWOT Analysis
9.4.3.3 Products & Services Offered
9.4.3.4 Strategic Alliances between Business Partners
9.4.4 Merck KGaA
9.4.4.1 Business Description & Financial Analysis
9.4.4.2 SWOT Analysis
9.4.4.3 Products & Services Offered
9.4.4.4 Strategic Alliances between Business Partners
9.4.5 Illumina, Inc.
9.4.5.1 Business Description & Financial Analysis
9.4.5.2 SWOT Analysis
9.4.5.3 Products & Services Offered
9.4.5.4 Strategic Alliances between Business Partners
9.4.6 Agilent Technologies, Inc.
9.4.6.1 Business Description & Financial Analysis
9.4.6.2 SWOT Analysis
9.4.6.3 Products & Services Offered
9.4.6.4 Strategic Alliances between Business Partners
9.4.7 Thermo Fisher Scientific, Inc.
9.4.7.1 Business Description & Financial Analysis
9.4.7.2 SWOT Analysis
9.4.7.3 Products & Services Offered
9.4.8.4 Strategic Alliances between Business Partners
9.4.8 Bio-Rad Laboratories, Inc.
9.4.8.1 Business Description & Financial Analysis
9.4.8.2 SWOT Analysis
9.4.8.3 Products & Services Offered
9.4.8.4 Strategic Alliances between Business Partners
9.4.9 F. Hoffmann-La Roche AG
9.4.9.1 Business Description & Financial Analysis
9.4.9.2 SWOT Analysis
9.4.9.3 Products & Services Offered
9.4.9.4 Strategic Alliances between Business Partners
9.4.10 Affymetrix, Inc.
9.4.10.1 Business Description & Financial Analysis
9.4.10.2 SWOT Analysis
9.4.10.3 Product Types & Services Offered
9.4.10.4 Strategic Alliances between Business Partners
9.4.11 Danaher
9.4.11.1 Business Description & Financial Analysis
9.4.11.2 SWOT Analysis
9.4.11.3 Product Types & Services Offered
9.4.11.4 Strategic Alliances between Business Partners
9.4.12 Eurofins Scientific
9.4.12.1 Business Description & Financial Analysis
9.4.12.2 SWOT Analysis
9.4.12.3 Product Types & Services Offered
9.4.12.4 Strategic Alliances between Business Partners
9.4.12 Other Companies
9.4.12.1 Business Description & Financial Analysis
9.4.12.2 SWOT Analysis
9.4.12.3 Product Types & Services Offered
9.4.12.4 Strategic Alliances between Business Partners
10 RESEARCH METHODOLOGY
10.1 Market Introduction
10.1.1 Market Definition
10.1.2 Market Scope & Segmentation
10.2 Information Procurement
10.2.1 Secondary Research
10.2.1.1 Purchased Databases
10.2.1.2 GMEs Internal Data Repository
10.2.1.3 Secondary Resources & Third Party Perspectives
10.2.1.4 Company Information Sources
10.2.2 Primary Research
10.2.2.1 Various Types of Respondents for Primary Interviews
10.2.2.2 Number of Interviews Conducted throughout the Research Process
10.2.2.3 Primary Stakeholders
10.2.2.4 Discussion Guide for Primary Participants
10.2.3 Expert Panels
10.2.3.1 Expert Panels Across 30+ Industry
10.2.4 Paid Local Experts
10.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
10.3 Market Estimation
10.3.1 Top-Down Approach
10.3.1.1 Macro-Economic Indicators Considered
10.3.1.2 Micro-Economic Indicators Considered
10.3.2 Bottom Up Approach
10.3.2.1 Company Share Analysis Approach
10.3.2.2 Estimation of Potential Product Type Sales
10.4 Data Triangulation
10.4.1 Data Collection
10.4.2 Time Series, Cross Sectional & Panel Data Analysis
10.4.3 Cluster Analysis
10.5 Analysis and Output
10.5.1 Inhouse AI Based Real Time Analytics Tool
10.5.2 Output From Desk & Primary Research
10.6 Research Assumptions & Limitations
10.7.1 Research Assumptions
10.7.2 Research Limitations
LIST OF TABLES
1 Global RNA Analysis Market, By Product Type, 2021-2029 (USD Million)
2 Instruments Market, By Region, 2021-2029 (USD Million)
3 Kits & Reagents Market, By Region, 2021-2029 (USD Million)
4 Services Market, By Region, 2021-2029 (USD Million)
5 Global RNA Analysis Market, By Technology, 2021-2029 (USD Million)
6 Real Time-PCR (qPCR) Market, By Region, 2021-2029 (USD Million)
7 Microarray Market, By Region, 2021-2029 (USD Million)
8 Sequencing Market, By Region, 2021-2029 (USD Million)
9 Others Market, By Region, 2021-2029 (USD Million)
10 Global RNA Analysis Market, By Application, 2021-2029 (USD Million)
11 Construction of RNA Expression Atlas Market, By Region, 2021-2029 (USD Million)
12 Epigenetics Market, By Region, 2021-2029 (USD Million)
13 Infectious Diseases & Pathogenesis Market, By Region, 2021-2029 (USD Million)
14 Alternative RNA Splicing Market, By Region, 2021-2029 (USD Million)
15 RNA Structure & Molecular Dynamics Market, By Region, 2021-2029 (USD Million)
16 Development & Delivery of RNA Therapeutics Market, By Region, 2021-2029 (USD Million)
17 Others Market, By Region, 2021-2029 (USD Million)
18 Global RNA Analysis Market, By End-use, 2021-2029 (USD Million)
19 Government Institutes & Academic Centers Market, By Region, 2021-2029 (USD Million)
20 Pharmaceutical & Biotechnology Companies Market, By Region, 2021-2029 (USD Million)
21 Hospitals & Clinics Market, By Region, 2021-2029 (USD Million)
22 Contract Research Organizations (CROs) Market, By Region, 2021-2029 (USD Million)
23 Regional Analysis, 2021-2029 (USD Million)
24 North America RNA Analysis Market, By Product Type, 2021-2029 (USD Million)
25 North America RNA Analysis Market, By Technology, 2021-2029 (USD Million)
26 North America RNA Analysis Market, By Application, 2021-2029 (USD Million)
27 North America RNA Analysis Market, By End-use, 2021-2029 (USD Million)
28 North America RNA Analysis Market, By Country, 2021-2029 (USD Million)
29 U.S. RNA Analysis Market, By Product Type, 2021-2029 (USD Million)
30 U.S. RNA Analysis Market, By Technology, 2021-2029 (USD Million)
31 U.S. RNA Analysis Market, By Application, 2021-2029 (USD Million)
32 U.S. RNA Analysis Market, By End-use, 2021-2029 (USD Million)
33 Canada RNA Analysis Market, By Product Type, 2021-2029 (USD Million)
34 Canada RNA Analysis Market, By Technology, 2021-2029 (USD Million)
35 Canada RNA Analysis Market, By Application, 2021-2029 (USD Million)
36 CANADA RNA Analysis Market, By End-use, 2021-2029 (USD Million)
37 Mexico RNA Analysis Market, By Product Type, 2021-2029 (USD Million)
38 Mexico RNA Analysis Market, By Technology, 2021-2029 (USD Million)
39 Mexico RNA Analysis Market, By Application, 2021-2029 (USD Million)
40 mexico RNA Analysis Market, By End-use, 2021-2029 (USD Million)
41 Europe RNA Analysis Market, By Product Type, 2021-2029 (USD Million)
42 Europe RNA Analysis Market, By Technology, 2021-2029 (USD Million)
43 Europe RNA Analysis Market, By Application, 2021-2029 (USD Million)
44 europe RNA Analysis Market, By End-use, 2021-2029 (USD Million)
45 europe RNA Analysis Market, By country, 2021-2029 (USD Million)
46 Germany RNA Analysis Market, By Product Type, 2021-2029 (USD Million)
47 Germany RNA Analysis Market, By Technology, 2021-2029 (USD Million)
48 Germany RNA Analysis Market, By Application, 2021-2029 (USD Million)
49 germany RNA Analysis Market, By End-use, 2021-2029 (USD Million)
50 U.K. RNA Analysis Market, By Product Type, 2021-2029 (USD Million)
51 U.K. RNA Analysis Market, By Technology, 2021-2029 (USD Million)
52 U.K. RNA Analysis Market, By Application, 2021-2029 (USD Million)
53 U.k. RNA Analysis Market, By End-use, 2021-2029 (USD Million)
54 France RNA Analysis Market, By Product Type, 2021-2029 (USD Million)
55 France RNA Analysis Market, By Technology, 2021-2029 (USD Million)
56 France RNA Analysis Market, By Application, 2021-2029 (USD Million)
57 france RNA Analysis Market, By End-use, 2021-2029 (USD Million)
58 Italy RNA Analysis Market, By Product Type, 2021-2029 (USD Million)
59 Italy RNA Analysis Market, By T Asset Type Type, 2021-2029 (USD Million)
60 Italy RNA Analysis Market, By Application, 2021-2029 (USD Million)
61 italy RNA Analysis Market, By End-use, 2021-2029 (USD Million)
62 Spain RNA Analysis Market, By Product Type, 2021-2029 (USD Million)
63 Spain RNA Analysis Market, By Technology, 2021-2029 (USD Million)
64 Spain RNA Analysis Market, By Application, 2021-2029 (USD Million)
65 spain RNA Analysis Market, By End-use, 2021-2029 (USD Million)
66 Rest Of Europe RNA Analysis Market, By Product Type, 2021-2029 (USD Million)
67 Rest Of Europe RNA Analysis Market, By Technology, 2021-2029 (USD Million)
68 Rest of Europe RNA Analysis Market, By Application, 2021-2029 (USD Million)
69 REST OF EUROPE RNA Analysis Market, By End-use, 2021-2029 (USD Million)
70 Asia Pacific RNA Analysis Market, By Product Type, 2021-2029 (USD Million)
71 Asia Pacific RNA Analysis Market, By Technology, 2021-2029 (USD Million)
72 Asia Pacific RNA Analysis Market, By Application, 2021-2029 (USD Million)
73 asia RNA Analysis Market, By End-use, 2021-2029 (USD Million)
74 Asia Pacific RNA Analysis Market, By Country, 2021-2029 (USD Million)
75 China RNA Analysis Market, By Product Type, 2021-2029 (USD Million)
76 China RNA Analysis Market, By Technology, 2021-2029 (USD Million)
77 China RNA Analysis Market, By Application, 2021-2029 (USD Million)
78 china RNA Analysis Market, By End-use, 2021-2029 (USD Million)
79 India RNA Analysis Market, By Product Type, 2021-2029 (USD Million)
80 India RNA Analysis Market, By Technology, 2021-2029 (USD Million)
81 India RNA Analysis Market, By Application, 2021-2029 (USD Million)
82 india RNA Analysis Market, By End-use, 2021-2029 (USD Million)
83 Japan RNA Analysis Market, By Product Type, 2021-2029 (USD Million)
84 Japan RNA Analysis Market, By Technology, 2021-2029 (USD Million)
85 Japan RNA Analysis Market, By Application, 2021-2029 (USD Million)
86 japan RNA Analysis Market, By End-use, 2021-2029 (USD Million)
87 South Korea RNA Analysis Market, By Product Type, 2021-2029 (USD Million)
88 South Korea RNA Analysis Market, By Technology, 2021-2029 (USD Million)
89 South Korea RNA Analysis Market, By Application, 2021-2029 (USD Million)
90 south korea RNA Analysis Market, By End-use, 2021-2029 (USD Million)
91 rest of Asia Pacific RNA Analysis Market, By Product Type, 2021-2029 (USD Million)
92 rest of Asia Pacific RNA Analysis Market, By Technology, 2021-2029 (USD Million)
93 rest of Asia Pacific RNA Analysis Market, By Application, 2021-2029 (USD Million)
94 rest of asia RNA Analysis Market, By End-use, 2021-2029 (USD Million)
95 Middle East and Africa RNA Analysis Market, By Product Type, 2021-2029 (USD Million)
96 Middle East and Africa RNA Analysis Market, By Technology, 2021-2029 (USD Million)
97 Middle East and Africa RNA Analysis Market, By Application, 2021-2029 (USD Million)
98 MIDDLE EAST and AFRICA RNA Analysis Market, By End-use, 2021-2029 (USD Million)
99 Middle East and Africa RNA Analysis Market, By Country, 2021-2029 (USD Million)
100 Saudi Arabia RNA Analysis Market, By Product Type, 2021-2029 (USD Million)
101 Saudi Arabia RNA Analysis Market, By Technology, 2021-2029 (USD Million)
102 Saudi Arabia RNA Analysis Market, By Application, 2021-2029 (USD Million)
103 saudi arabia RNA Analysis Market, By End-use, 2021-2029 (USD Million)
104 UAE RNA Analysis Market, By Product Type, 2021-2029 (USD Million)
105 UAE RNA Analysis Market, By Technology, 2021-2029 (USD Million)
106 UAE RNA Analysis Market, By Application, 2021-2029 (USD Million)
107 uae RNA Analysis Market, By End-use, 2021-2029 (USD Million)
108 rest of Middle East and Africa RNA Analysis Market, By Product Type, 2021-2029 (USD Million)
109 rest of Middle East and Africa RNA Analysis Market, By Technology, 2021-2029 (USD Million)
110 rest of Middle East and Africa RNA Analysis Market, By Application, 2021-2029 (USD Million)
111 rest of MIDDLE EAST and AFRICA RNA Analysis Market, By End-use, 2021-2029 (USD Million)
112 Central and South America RNA Analysis Market, By Product Type, 2021-2029 (USD Million)
113 Central and South America RNA Analysis Market, By Technology, 2021-2029 (USD Million)
114 Central and South America RNA Analysis Market, By Application, 2021-2029 (USD Million)
115 CENTRAL and SOUTH AMERICA RNA Analysis Market, By End-use, 2021-2029 (USD Million)
116 Central and South America RNA Analysis Market, By Country, 2021-2029 (USD Million)
117 Brazil RNA Analysis Market, By Product Type, 2021-2029 (USD Million)
118 Brazil RNA Analysis Market, By Technology, 2021-2029 (USD Million)
119 Brazil RNA Analysis Market, By Application, 2021-2029 (USD Million)
120 brazil RNA Analysis Market, By End-use, 2021-2029 (USD Million)
121 rest of Central and South America RNA Analysis Market, By Product Type, 2021-2029 (USD Million)
122 rest of Central and South America RNA Analysis Market, By Technology, 2021-2029 (USD Million)
123 rest of Central and South America RNA Analysis Market, By Application, 2021-2029 (USD Million)
124 rest of CENTRAL and SOUTH AMERICA RNA Analysis Market, By End-use, 2021-2029 (USD Million)
125 Pacific Bioscience of California, Inc.: Products & Services Offering
126 Promega: Products & Services Offering
127 QIAGEN: Products & Services Offering
128 Merck KGaA: Products & Services Offering
129 Illumina, Inc.: Products & Services Offering
130 AGILENT TECHNOLOGIES, INC.: Products & Services Offering
131 Thermo Fisher Scientific, Inc. : Products & Services Offering
132 Bio-Rad Laboratories, Inc.: Products & Services Offering
133 F. Hoffmann-La Roche AG, Inc: Products & Services Offering
134 Affymetrix, Inc.: Products & Services Offering
135 Danaher: Products & Services Offering
136 Eurofins Scientific: Products & Services Offering
137 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global RNA Analysis Market Overview
2 Global RNA Analysis Market Value From 2021-2029 (USD Million)
3 Global RNA Analysis Market Share, By Product Type (2023)
4 Global RNA Analysis Market Share, By Technology (2023)
5 Global RNA Analysis Market Share, By Application (2023)
6 Global RNA Analysis Market Share, By End-use (2023)
7 Global RNA Analysis Market, By Region (Asia Pacific Market)
8 Technological Trends In Global RNA Analysis Market
9 Four Quadrant Competitor Positioning Matrix
10 Impact Of Macro & Micro Indicators On The Market
11 Impact Of Key Drivers On The Global RNA Analysis Market
12 Impact Of Challenges On The Global RNA Analysis Market
13 Porter’s Five Forces Analysis
14 Global RNA Analysis Market: By Product Type Scope Key Takeaways
15 Global RNA Analysis Market, By Product Type Segment: Revenue Growth Analysis
16 Instruments Market, By Region, 2021-2029 (USD Million)
17 Kits & Reagents Market, By Region, 2021-2029 (USD Million)
18 Services Market, By Region, 2021-2029 (USD Million)
19 Global RNA Analysis Market: By Technology Scope Key Takeaways
20 Global RNA Analysis Market, By Technology Segment: Revenue Growth Analysis
21 Real Time-PCR (qPCR) Market, By Region, 2021-2029 (USD Million)
22 Microarray Market, By Region, 2021-2029 (USD Million)
23 Sequencing Market, By Region, 2021-2029 (USD Million)
24 Others Market, By Region, 2021-2029 (USD Million)
25 Global RNA Analysis Market: By Application Scope Key Takeaways
26 Global RNA Analysis Market, By Application Segment: Revenue Growth Analysis
27 Construction of RNA Expression Atlas Market, By Region, 2021-2029 (USD Million)
28 Epigenetics Market, By Region, 2021-2029 (USD Million)
29 Infectious Diseases & Pathogenesis Market, By Region, 2021-2029 (USD Million)
30 Alternative RNA Splicing Market, By Region, 2021-2029 (USD Million)
31 RNA Structure & Molecular Dynamics Market, By Region, 2021-2029 (USD Million)
32 Development & Delivery of RNA Therapeutics Market, By Region, 2021-2029 (USD Million)
33 Others Market, By Region, 2021-2029 (USD Million)
34 Global RNA Analysis Market: By End-use Scope Key Takeaways
35 Global RNA Analysis Market, By End-use Segment: Revenue Growth Analysis
36 Government Institutes & Academic Centers Market, By Region, 2021-2029 (USD Million)
37 Pharmaceutical & Biotechnology Companies Market, By Region, 2021-2029 (USD Million)
38 Hospitals & Clinics Market, By Region, 2021-2029 (USD Million)
39 Contract Research Organizations (CROs) Market, By Region, 2021-2029 (USD Million)
40 Regional Segment: Revenue Growth Analysis
41 Global RNA Analysis Market: Regional Analysis
42 North America RNA Analysis Market Overview
43 North America RNA Analysis Market, By Product Type
44 North America RNA Analysis Market, By Technology
45 North America RNA Analysis Market, By Application
46 North America RNA Analysis Market, By End-use
47 North America RNA Analysis Market, By Country
48 U.S. RNA Analysis Market, By Product Type
49 U.S. RNA Analysis Market, By Technology
50 U.S. RNA Analysis Market, By Application
51 U.S. RNA Analysis Market, By End-use
52 Canada RNA Analysis Market, By Product Type
53 Canada RNA Analysis Market, By Technology
54 Canada RNA Analysis Market, By Application
55 Canada RNA Analysis Market, By End-use
56 Mexico RNA Analysis Market, By Product Type
57 Mexico RNA Analysis Market, By Technology
58 Mexico RNA Analysis Market, By Application
59 Mexico RNA Analysis Market, By End-use
60 Four Quadrant Positioning Matrix
61 Company Market Share Analysis
62 Pacific Bioscience of California, Inc.: Company Snapshot
63 Pacific Bioscience of California, Inc.: SWOT Analysis
64 Pacific Bioscience of California, Inc.: Geographic Presence
65 Promega: Company Snapshot
66 Promega: SWOT Analysis
67 Promega: Geographic Presence
68 QIAGEN: Company Snapshot
69 QIAGEN: SWOT Analysis
70 QIAGEN: Geographic Presence
71 Merck KGaA: Company Snapshot
72 Merck KGaA: Swot Analysis
73 Merck KGaA: Geographic Presence
74 Illumina, Inc.: Company Snapshot
75 Illumina, Inc.: SWOT Analysis
76 Illumina, Inc.: Geographic Presence
77 Agilent Technologies, Inc.: Company Snapshot
78 Agilent Technologies, Inc.: SWOT Analysis
79 Agilent Technologies, Inc.: Geographic Presence
80 Thermo Fisher Scientific, Inc. : Company Snapshot
81 Thermo Fisher Scientific, Inc. : SWOT Analysis
82 Thermo Fisher Scientific, Inc. : Geographic Presence
83 Bio-Rad Laboratories, Inc.: Company Snapshot
84 Bio-Rad Laboratories, Inc.: SWOT Analysis
85 Bio-Rad Laboratories, Inc.: Geographic Presence
86 F. Hoffmann-La Roche AG, Inc.: Company Snapshot
87 F. Hoffmann-La Roche AG, Inc.: SWOT Analysis
88 F. Hoffmann-La Roche AG, Inc.: Geographic Presence
89 Affymetrix, Inc.: Company Snapshot
90 Affymetrix, Inc.: SWOT Analysis
91 Affymetrix, Inc.: Geographic Presence
92 Danaher: Company Snapshot
93 Danaher: SWOT Analysis
94 Danaher: Geographic Presence
95 Other Companies: Company Snapshot
96 Other Companies: SWOT Analysis
97 Other Companies: Geographic Presence
The Global RNA Analysis Market has been studied from the year 2019 till 2029. However, the CAGR provided in the report is from the year 2024 to 2029. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the RNA Analysis Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
